David Dermot Patrick Laffan
AstraZeneca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David Dermot Patrick Laffan.
Organic and Biomolecular Chemistry | 2006
John S. Carey; David Dermot Patrick Laffan; Colin Thomson; Michael Trevelyan Williams
The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer.
Tetrahedron Letters | 1988
Ian Paterson; David Dermot Patrick Laffan; David J. Rawson
Abstract The enantiomerically-pure 14-membered ring macrolide 1 is prepared in 14 steps from the racemic aldehyde 4, Z=SPh. The C2-C4 and C8-C10 stereorelationships in 1 are controlled in a single step by an Evans aldol condensation with (±)-4. Macrolactonisation, 23 → 1, takes place in high yield (91%).
Angewandte Chemie | 2007
Erik Kühnel; David Dermot Patrick Laffan; Guy C. Lloyd-Jones; Teresa Martínez del Campo; Ian R. Shepperson; Jennifer L. Slaughter
Archive | 2004
Tetsuo Okada; John Horbury; David Dermot Patrick Laffan
Archive | 2001
Robert Stevenson; Fraser Kerr; Anthony Raymond Lane; Eve Joanne Brazier; Phillip John Hogan; David Dermot Patrick Laffan
Tetrahedron | 2006
Guy C. Lloyd-Jones; Philip D. Wall; Jennifer L. Slaughter; Alexandra J. Parker; David Dermot Patrick Laffan
Tetrahedron Letters | 2004
Michael J. Porter; Nicola White; Garnet Howells; David Dermot Patrick Laffan
Archive | 2017
David Dermot Patrick Laffan; Kay Alison Boardman; Oliver Robert Cunningham; William R. F. Goundry
Archive | 2010
Kay Alison Boardman; Oliver Robert Cunningham; William R. F. Goundry; David Dermot Patrick Laffan
Archive | 2004
John Horbury; David Dermot Patrick Laffan; Tetsuo Okada